nitroaspirin has been researched along with concanavalin a in 1 studies
| Studies (nitroaspirin) | Trials (nitroaspirin) | Recent Studies (post-2010) (nitroaspirin) | Studies (concanavalin a) | Trials (concanavalin a) | Recent Studies (post-2010) (concanavalin a) |
|---|---|---|---|---|---|
| 127 | 9 | 8 | 17,959 | 82 | 1,337 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antonelli, E; Del Sero, G; Del Soldato, P; Distrutti, E; Federici, B; Fiorucci, S; Morelli, A; Morelli, O; Romani, L; Santucci, L | 1 |
1 other study(ies) available for nitroaspirin and concanavalin a
| Article | Year |
|---|---|
NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines.
Topics: Amino Acid Chloromethyl Ketones; Animals; Aspirin; Caspase 1; Caspase 3; Caspase Inhibitors; Caspases; Chemical and Drug Induced Liver Injury; Concanavalin A; Cysteine Proteinase Inhibitors; Cytokines; Fas Ligand Protein; fas Receptor; Interferon-gamma; Interleukin-18; Interleukins; Liver; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Platelet Aggregation Inhibitors; Receptors, Interleukin-2; RNA, Messenger; Spleen; T-Lymphocytes; Th1 Cells; Transcription, Genetic; Up-Regulation | 2000 |